Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News BioMerieux reports double-digit organic growth in Q1 2016

BioMerieux reports double-digit organic growth in Q1 2016

26th April 2016

BioMerieux has announced its financial results for the first quarter of 2016, during which it delivered a sales total of 489 million euros (379.19 million pounds).

This represented a year-on-year improvement of 11.5 percent at constant exchange rates and scope of consolidation, or 9.5 percent on a reported basis. The improvement was driven primarily by a 22.5 percent sales improvement in the Americas.

Its clinical microbiology unit saw great success during the quarter, with revenues up by 6.7 percent, driven primarily by successful sales of the Vitek and BacT/Alert lines. Meanwhile, its FilmArray Torch high-throughput system achieved key regulatory milestones in the US and EU.

Encouraging FilmArray sales were recorded despite a weaker flu season that also began later than in the same period of 2015, highlighting the underlying strength of the business.

Alexandre Merieux, chief executive officer of BioMerieux, said: "Backed by our solid first-quarter 2016 performance, we are continuing our drive to enhance operating efficiency in line with our strategic roadmap and our full-year objectives."ADNFCR-8000103-ID-801817353-ADNFCR

We currently have 10 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.